There is a clear trend to increase our resources on German translation and updates of Evidence Based Medicine Guidelines. This coincides with the decision to join forces with EBSCO Health and provide federated on-line search of German EBMG and DynaMed Plus.<\/p>\n
Duodecim Medical Publications Ltd have appointed GELIAM (Gesellschaft f\u00fcr Evidenz- und Leitlinienimplementierung in der Allgemeinmedizin) to take the responsibility to translate EBMG and to localize the content into German speaking markets.\u00a0 The team will be headed by Prof. Dr. med. Andreas S\u00f6nnichsen, University of Witten \/ Herdecke and Dr. Susanne Rabady. Both have extensive experience in guideline production and EBMG translation in Germany as well as in Austria and Switzerland.<\/p>\n
\u201cWith increased resources we look forward to serving German, Austrian and Swiss medical communities with even richer content and more frequent updates\u201d, states prof. S\u00f6nnischen. \u201cIt is interesting to note, that users are moving rapidly from textbooks into web based solutions and tablets and we need to meet that demand\u201d, says Dr. Rabady.<\/p>\n
\u201cThis partnership serves well our strategy to increase the presence of our medical content in several German speaking countries. It will also have a significant contribution to our clinical decision support system (EBMeDS\u00ae<\/sup>) in those countries\u201d, comments Dr. Pekka Mustonen, CEO of Duodecim Medical Publications Ltd.<\/p>\n For more information:<\/p>\n Prof. Dr. med. Andreas S\u00f6nnichsen; GELIAM, andreas.soennichsen at uni-wh.de<\/p>\n Mr. Timo Haikonen; Duodecim Medical Publications Ltd; timo.haikonen at duodecim.fi<\/p>\n